The Cracking Cancer Podcast
The Cracking Cancer Podcast
Podcast Description
Welcome to Cracking Cancer, a podcast dedicated to breaking down the knowledge and cultural barriers between patients and healthcare providers. Our mission is to empower listeners with clear, accessible insights into cancer care and treatment options. Through expert interviews, patient stories, and Q&A, we aim to create a more informed and supportive cancer community. Join us as we crack the code to better communication, knowledge, and collaboration in the fight against cancer.
Podcast Insights
Content Themes
Topics explored in Cracking Cancer include cancer biology, treatment options, emotional aspects of cancer, and the importance of community support. For instance, episodes discuss the significance of molecular profiling and how lifestyle factors can impact cancer, alongside personal narratives like Samantha Murrell's journey with stage four lung cancer.
Join Dr. Kyle Concannon, an MD Anderson–trained cancer doctor and scientist, together with the patient community, as we break down the knowledge and cultural barriers between cancer patients and cancer providers. Cracking Cancer empowers listeners with clear, accessible insights into cancer care, treatment options, and the complex world of cancer. Here, academic experts (providers) and experiential experts (patients) come together to discuss critical topics and build a more informed, supportive cancer community. Join us as we crack the code to better communication, knowledge, and collaboration in the fight against cancer. This podcast is intended for informational purposes only. It does not constitute medical advice and should not be relied upon as such. The views expressed are those of the participants and not of their affiliated organizations.
The Ethics and Impacts of Clinical Trial Prediction Markets
In this episode of Cracking Cancer, host Dr. Kyle Concannon is joined by patient advocate Samantha Murrell and science communicator Rob Swanda, PhD, to tackle an unforeseen intersection in modern medicine: the rise of prediction markets on clinical trial outcomes. The panel dissects the recent introduction of prediction markets for FDA regulatory approvals and Phase 3 trial endpoints—including progression-free survival (PFS) and overall survival (OS).
The team explores the severe moral and psychological ramifications of treating life-saving medical research like a sports wager. Samantha shares the distressing reality for cancer patients facing a Phase 3 trial, who may now see public financial markets actively “b*****g against” their treatment’s success. Dr. Kyle and Rob analyze how these speculative markets risk introducing profound biases into clinical trial measurements, threatening patient enrollment, compromising investigator objectivity, and reducing complex biological discoveries down to binary, short-term financial wagers.
Key Takeaways:
- The Arrival of Clinical Trial Prediction Markets
- The Psychological Toll on Enrolled Patients
- Unconscious Bias in Scan Measurement
- Erosion of Scientific Nuance
- Ethical and Insider Trading Vulnerabilities
Want to get more involved with cancer research and support the podcast? Visit the link below: ⬇️ (All proceeds go strictly towards furthering cancer research and supporting this podcast)
Chapters:
00:00 B*****g On Trials
02:47 Patient Advocate Reaction
05:03 Hope And Harm
09:24 Endpoints Explained
11:25 How Trial Data Forms
12:40 Bias And Measurement
17:29 Insider Info Risks
25:01 Threats And Coercion
39:04 Negative Trials Still Help
47:57 Symptom Bias And Reporting
59:07 Better Things To B** On
To find out more about supporting the show and research endeavors, please go to the following website: www.crackingcancer.org
Attributions
The music track – Progression Pulse – is provided by Denys Brodovskyi through the Attribution 4.0 International License
X: (1) Cracking Cancer Podcast (@Cracking_Cancer) / X
IG: Cracking Cancer (@crackingcancerpodcast) • Instagram photos and videos
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.